Dr Yoon Sung Nam from the Korea Advanced Institute of Science and Technology at Daejeon, Republic of Korea was awarded for his short oral presentation about “Efficient in vivo phage therapy via immunological cloaking” during Phage Therapy & Antibiotic Resistance Congress 2018.
The aim of Dr Nam’s study was to “immunologically cloaked T7 phage to reduce phagocytosis through genetic expression of CD47-derived self-peptide. […]”.
In their study, Dr Nam and his team “demonstrated that the in vivo anti-bacterial activity of lytic T7 phage can be dramatically increased by prolonged blood circulation through immunological cloaking with the self-peptide.”
The scientific committee